Print

HVTN 048

A phase I dose-escalation clinical trial to evaluate the safety and immunogenicity of the EP HIV-1090 DNA vaccine in healthy, HIV-1 uninfected adult participants

Trial Details:

I Completed
HIV Vaccine Trials Network (HVTN) April 01, 2003
EP HIV-1090 21 highly specific CTL epitopes for Gag, Pol, Env, Nef, Rev and Vpr, from all of the major subtypes and CRF
EP HIV-1090 DNA
Botswana, USA 42
NCT00054860
http://clinicaltrials.gov/show/NCT00054860